{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:44:32Z","timestamp":1760240672188,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Symmetry"],"abstract":"<jats:p>Indirubin derivatives and analogues are a large group of compounds which are widely and successfully used in treatment of many cancer diseases. In particular, the ChEMBL474807 molecule, which has confirmed inhibiting abilities against CDK2 and GSK3B enzymes, can be included in this group. The immobilization of inhibitors with the use of nanocarriers is an often used strategy in creation of targeted therapies. Evaluations were made of the possibility of immobilizing ligand molecules on different types of nanocarrier, such as carbon nanotubes (CNT), functionalized fullerene C60 derivatives (FF_X), and functionalized cube rhombellanes, via the use of docking methods. All results were compared with a reference system, namely C60 fullerene. The realized calculations allowed indication of a group of compounds that exhibited significant binding affinity relative to the ligand molecule. Obtained data shows that structural modifications, such as those related to the addition of functional groups or changes of structure symmetry, realized in particular types of considered nanostructures, can contribute to increases of their binding capabilities. The analysis of all obtained nano complexes clearly shows that the dominant role in stabilization of such systems is played by stacking and hydrophobic interactions. The realized research allowed identification of potential nanostructures that, together with the ChEMBL474807 molecule, enable the creation of targeted therapy.<\/jats:p>","DOI":"10.3390\/sym11080980","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T11:58:16Z","timestamp":1564747096000},"page":"980","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Immobilization of ChEMBL474807 Molecules Using Different Classes of Nanostructures"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7268-4956","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Czele\u0144","sequence":"first","affiliation":[{"name":"Department of Physical Chemistry, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Kurpinskiego 5, 85-096 Bydgoszcz, Poland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8433-3520","authenticated-orcid":false,"given":"Beata","family":"Szefler","sequence":"additional","affiliation":[{"name":"Department of Physical Chemistry, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Kurpinskiego 5, 85-096 Bydgoszcz, Poland"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(00)00879-7","article-title":"Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity","volume":"410","author":"Kunikata","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2011.03.006","article-title":"5\u2032-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin \u03b21\/FAK\/Akt signaling","volume":"306","author":"Kim","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1158\/0008-5472.CAN-10-3026","article-title":"Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments","volume":"71","author":"Williams","year":"2011","journal-title":"Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Shin, E.-K., and Kim, J.-K. (2012). Indirubin derivative E804 inhibits angiogenesis. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-164"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/jnr.22723","article-title":"The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons","volume":"89","author":"Martin","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s11224-016-0803-0","article-title":"Molecular dynamics study on inhibition mechanism of CDK-2 and GSK-3\u03b2 by CHEMBL272026 molecule","volume":"27","year":"2016","journal-title":"Struct. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00894-017-3395-8","article-title":"Inhibition mechanism of CDK-2 and GSK-3\u03b2 by a sulfamoylphenyl derivative of indoline\u2014a molecular dynamics study","volume":"23","year":"2017","journal-title":"J. Mol. Model."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/bjoc.2000.1546","article-title":"Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells","volume":"84","author":"Marko","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/9035","article-title":"Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases","volume":"1","author":"Hoessel","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1080\/1042819021000006295","article-title":"Indirubin and Meisoindigo in the Treatment of Chronic Myelogenous Leukemia in China","volume":"43","author":"Xiao","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3892\/or.2013.2334","article-title":"Indirubin-3\u2032-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells","volume":"29","author":"Lee","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00894-015-2627-z","article-title":"Molecular dynamics study of the inhibitory effects of ChEMBL474807 on the enzymes GSK-3\u03b2 and CDK-2","volume":"21","author":"Szefler","year":"2015","journal-title":"J. Mol. Model."},{"key":"ref_13","first-page":"133","article-title":"Drug delivery and nanoparticles:applications and hazards","volume":"3","author":"Borm","year":"2008","journal-title":"Int. J. Nanomedicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2012.05.051","article-title":"Nanotechnology applied to overcome tumor drug resistance","volume":"162","author":"Gao","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11095-011-0558-7","article-title":"Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug","volume":"29","author":"Morgen","year":"2012","journal-title":"Pharm. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10856-011-4237-3","article-title":"Low-temperature 1H-NMR spectroscopic study of doxorubicin influence on the hydrated properties of nanosilica modified by DNA","volume":"22","author":"Turov","year":"2011","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.msec.2011.02.026","article-title":"Interaction of N-fluorescein-5-isothiocyanate pyrrolidine-C60 with a bimolecular lipid model membrane","volume":"31","author":"Schuetze","year":"2011","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/cphc.201200938","article-title":"Complexation of C60 Fullerene with Aromatic Drugs","volume":"14","author":"Evstigneev","year":"2013","journal-title":"ChemPhysChem"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1021\/nl062515f","article-title":"Translocation of C60 and Its Derivatives Across a Lipid Bilayer","volume":"7","author":"Qiao","year":"2007","journal-title":"Nano Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1166\/jbn.2012.1404","article-title":"Water-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane","volume":"8","author":"Prylutska","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/mawe.200900433","article-title":"Comparative study of biological action of fullerenes C60 and carbon nanotubes in thymus cells","volume":"40","author":"Prylutska","year":"2009","journal-title":"Materwiss. Werksttech."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfp265","article-title":"The Biological Mechanisms and Physicochemical Characteristics Responsible for Driving Fullerene Toxicity","volume":"114","author":"Johnston","year":"2010","journal-title":"Toxicol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/15363830500237267","article-title":"Is the C60 Fullerene Molecule Toxic?!","volume":"13","author":"Andrievsky","year":"2005","journal-title":"Fuller. Nanotub. Carbon Nanostructures"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1254\/jphs.CPJ06002X","article-title":"Pharmacological studies on fullerene (C60), a novel carbon allotrope, and its derivatives","volume":"100","author":"Satoh","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.biomaterials.2008.09.061","article-title":"The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials","volume":"30","author":"Yin","year":"2009","journal-title":"Biomaterials"},{"key":"ref_26","first-page":"261","article-title":"Biomedical applications of functionalized fullerene-based nanomaterials","volume":"4","author":"Partha","year":"2009","journal-title":"Int. J. Nanomedicine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/cb500135f","article-title":"An inhibitor\u2019s-eye view of the ATP-binding site of CDKs in different regulatory states","volume":"9","author":"Echalier","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Simon, J., Flahaut, E., and Golzio, M. (2019). Overview of Carbon Nanotubes for Biomedical Applications. Materials, 12.","DOI":"10.3390\/ma12040624"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/ja805721p","article-title":"Antioxidant Single-Walled Carbon Nanotubes","volume":"131","author":"Moore","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Czele\u0144, P., and Szefler, B. (2019). The Immobilization of Oxindole Derivatives with Use of Cube Rhombellane Homeomorphs. Symmetry, 11.","DOI":"10.3390\/sym11070900"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Szefler, B., and Czele\u0144, P. (2019). Docking of Cisplatin on Fullerene Derivatives and Some Cube Rhombellane Functionalized Homeomorphs. Symmetry, 11.","DOI":"10.3390\/sym11070874"},{"key":"ref_32","first-page":"7","article-title":"Docking of indolizine derivatives on cube rhombellane functionalized homeomorphs","volume":"63","author":"Szefler","year":"2018","journal-title":"Stud. Univ. Babes-Bolyai Chem."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Diudea, M.V., Lungu, C.N., Nagy, C.L., Diudea, M.V., Lungu, C.N., and Nagy, C.L. (2018). Cube-Rhombellane Related Structures: A Drug Perspective. Molecules, 23.","DOI":"10.3390\/molecules23102533"},{"key":"ref_34","unstructured":"(2014, February 02). CHEMBL database release 24.1. Available online: https:\/\/www.ebi.ac.uk\/chembl\/."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11429","DOI":"10.1038\/ncomms11429","article-title":"Protein-directed self-assembly of a fullerene crystal","volume":"7","author":"Kim","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_36","unstructured":"(2019, May 05). PubChem, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1023\/A:1023611131068","article-title":"A Method for Multiconformational Modeling of the Three-Dimensional Shape of a Molecule","volume":"43","author":"Bartashevich","year":"2002","journal-title":"J. Struct. Chem."}],"container-title":["Symmetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-8994\/11\/8\/980\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:12:35Z","timestamp":1760188355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-8994\/11\/8\/980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["sym11080980"],"URL":"https:\/\/doi.org\/10.3390\/sym11080980","relation":{},"ISSN":["2073-8994"],"issn-type":[{"type":"electronic","value":"2073-8994"}],"subject":[],"published":{"date-parts":[[2019,8,2]]}}}